Primary |
Chronic Gastritis |
28.6% |
Reflux Oesophagitis |
28.6% |
Gastritis |
14.3% |
Gastroesophageal Reflux |
14.3% |
Self Injurious Behaviour |
14.3% |
|
Dysphonia |
22.2% |
Asthma |
11.1% |
Cystitis |
11.1% |
Purpura |
11.1% |
Renal Impairment |
11.1% |
Self Injurious Behaviour |
11.1% |
Tremor |
11.1% |
Vomiting |
11.1% |
|
Secondary |
Product Used For Unknown Indication |
27.6% |
Drug Use For Unknown Indication |
12.8% |
Hypertension |
10.3% |
Gastric Ulcer |
5.0% |
Asthma |
4.7% |
Rheumatoid Arthritis |
4.3% |
Gastrooesophageal Reflux Disease |
3.7% |
Insomnia |
3.6% |
Prophylaxis |
3.5% |
Cardiac Failure |
3.3% |
Helicobacter Infection |
3.1% |
Renal Transplant |
2.4% |
Depression |
2.3% |
Relapsing-remitting Multiple Sclerosis |
2.1% |
Chronic Hepatitis C |
2.0% |
Gastritis |
2.0% |
Essential Hypertension |
1.9% |
Colitis Ulcerative |
1.8% |
Hyperlipidaemia |
1.8% |
Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
|
Malaise |
8.2% |
Rash |
8.2% |
Hepatic Function Abnormal |
5.7% |
Hepatitis Fulminant |
5.7% |
Interstitial Lung Disease |
5.7% |
Renal Failure Acute |
5.7% |
Rhabdomyolysis |
5.7% |
Thrombocytopenia |
5.7% |
Toxic Skin Eruption |
5.7% |
Hyponatraemia |
4.9% |
Agranulocytosis |
4.1% |
Erythema Multiforme |
4.1% |
Gamma-glutamyltransferase Increased |
4.1% |
Liver Injury |
4.1% |
Pancreatic Carcinoma |
4.1% |
Septic Shock |
4.1% |
Tremor |
4.1% |
Eosinophil Count Increased |
3.3% |
Gynaecomastia |
3.3% |
Hepatic Encephalopathy |
3.3% |
|
Concomitant |
Product Used For Unknown Indication |
13.9% |
Drug Use For Unknown Indication |
13.5% |
Prophylaxis |
13.0% |
Rheumatoid Arthritis |
12.1% |
Hypertension |
9.7% |
Chronic Hepatitis C |
5.7% |
Constipation |
3.6% |
Diabetes Mellitus |
3.3% |
Insomnia |
3.3% |
Pain |
2.5% |
Gastritis |
2.5% |
Osteoporosis |
2.4% |
Hepatitis C |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Gastric Ulcer |
2.0% |
Colitis Ulcerative |
1.9% |
Multiple Myeloma |
1.8% |
Renal Transplant |
1.6% |
Depression |
1.6% |
Hepatic Neoplasm Malignant |
1.5% |
|
Vomiting |
11.9% |
White Blood Cell Count Decreased |
10.0% |
Pyrexia |
9.5% |
Rash |
6.2% |
Pneumonia |
6.0% |
Interstitial Lung Disease |
5.9% |
Thrombocytopenia |
4.9% |
Platelet Count Decreased |
4.6% |
Renal Impairment |
4.6% |
Weight Decreased |
4.1% |
Renal Failure Acute |
4.0% |
Stomatitis |
3.9% |
Renal Failure |
3.6% |
White Blood Cell Count Increased |
3.2% |
Malaise |
3.1% |
Anaemia |
3.0% |
Nausea |
3.0% |
Weight Increased |
3.0% |
Sepsis |
2.9% |
Hepatic Function Abnormal |
2.6% |
|
Interacting |
Hypertension |
15.4% |
Cough |
11.5% |
Depression |
11.5% |
Neuralgia |
11.5% |
Non-small Cell Lung Cancer Metastatic |
11.5% |
Cancer Pain |
7.7% |
Hypocalcaemia |
7.7% |
Product Used For Unknown Indication |
7.7% |
Acute Hiv Infection |
3.8% |
Gastric Ulcer |
3.8% |
Gastrointestinal Disorder |
3.8% |
Hypercholesterolaemia |
3.8% |
|
Feeling Abnormal |
40.0% |
Drug Interaction |
30.0% |
Myocardial Infarction |
10.0% |
Tongue Oedema |
10.0% |
Varicose Ulceration |
10.0% |
|